AKT1 and neoplasm: The antitumor effects of these NPs were tested using mouse colon cancer cells and in vivo mouse tumor models, in which it was proven that cellular uptake was enhanced and neoplasm proliferation was reduced via effective downregulation of Akt1 [182].